Synthesis and 5-Hydroxytryptamine (5-HT) activity of 2,3,4,4a-Tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5-(6H)ones and 2,3,4,4a,5,6-Hexahydro-1H-pyrazino[1,2-a]quinoxalines
-
Published:2000-09
Issue:17
Volume:10
Page:1991-1994
-
ISSN:0960-894X
-
Container-title:Bioorganic & Medicinal Chemistry Letters
-
language:en
-
Short-container-title:Bioorganic & Medicinal Chemistry Letters
Author:
Welmaker Gregory S,Nelson James A,Sabalski Joan E,Sabb Annmarie L,Potoski John R,Graziano Denise,Kagan Michael,Coupet Joseph,Dunlop John,Mazandarani Hossein,Rosenzweig-Lipson Sharon,Sukoff Stacey,Zhang Yingxin
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference16 articles.
1. (a) For a recent review of central 5-HT receptors and their function, see: Barnes, N. M.; Sharp, T. Neuropharmacology 1999, 38, 1083. (b) Dekeyne, A.; Girardon, S.; Millan, M. J. Neuropharmacology 1999, 38, 415 and references therein. (c) Martin, J. R.; Bös, M.; Jenck, F.; Moreau, J.-L.; Mutel, V.; Sleight, A. J.; Wichmann, J.; Andrews, J. S.; Berendsen, H. H. G.; Broekkamp, C. L. E.; Ruigt, G. S. F.; Köhler, C.; van Delft, A. M. L. J. Pharmacol. Exp. Ther. 1998, 286, 913. 2. (a) Glennon, R. A.; Dukat, M. In Psychopharmacology: The Fourth Generation of Progress; Bloom, F. E., Kupfer, D. J., Eds.; Raven: New York, 1995; pp 415–429. (b) Molineaux, S. M.; Jesseli, T. M.; Axel, R.; Julius, D. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 6793. (c) Tecott, L. H.; Sun, L. M.; Akana, S. F.; Strack, A. M.; Lowenstein, D. H.; Dallman, M. F.; Julius, D. Nature 1995, 374, 542. 3. Obesity 4. Orlistat, a New Lipase Inhibitor for the Management of Obesity
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|